{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-013779","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.014598+00:00","generated_at":"2026-06-25T14:42:07.578127+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MariMed Q1 revenue up 27% to $31.3M; adj EBITDA $10.4M, guidance reaffirmed","bullets":["Revenue $31.3M (up 27% YoY); gross margin 54.3% vs 53.5%; net income $4.2M (flat YoY).","Non-GAAP adjusted EBITDA $10.4M (+29% YoY); cash from operations $8.5M; working capital $20.1M.","Closed Maryland and Illinois acquisitions post-quarter; plans CSE listing to boost liquidity.","FY 2022 guidance held: revenue $145-150M, gross margin 54-55%, adj EBITDA $47-52M, capex ~$25M.","Retail dispensary revenue grew 41% YoY; wholesale up 6%; launched THC-infused drink mixes in MA."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-013779","json":"https://secwatch.observer/filing/0001493152-22-013779.json","markdown":"https://secwatch.observer/filing/0001493152-22-013779.md","text":"https://secwatch.observer/filing/0001493152-22-013779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/0001493152-22-013779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T14:42:07.578127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}